CLSD CLSD

Clearside Biomedical Stock Price

1.525
-0.005 (-0.33%)
Upgrade to Real-Time
Regular Market
1.525
Volume 40,113
Bid Price 1.52
Ask Price 1.53
News -
Day High 1.53

Low
1.26

52 Week Range

High
7.73

Day Low 1.46
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Clearside Biomedical Inc CLSD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.005 -0.33% 1.525 14:26:57
Open Price Low Price High Price Close Price Prev Close
1.53 1.46 1.53 1.53
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
315 40,113 $ 1.50 $ 60,267 - 1.26 - 7.73
Last Trade Time Type Quantity Stock Price Currency
14:29:36 1 $ 1.525 USD

Period:

Draw Mode:

Clearside Biomedical Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 91.73M 60.15M 54.44M $ 29.58M $ -109.43k 0.01 160.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 30.00k 9.00%

more financials information »

Clearside Biomedical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CLSD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.571.731.461.62135,760-0.045-2.87%
1 Month1.301.731.261.43179,8640.22517.31%
3 Months2.362.441.261.63246,629-0.835-35.38%
6 Months2.722.951.261.97650,750-1.20-43.93%
1 Year4.767.731.263.68676,148-3.24-67.96%
3 Years0.99577.730.563.10831,8300.529353.16%
5 Years9.6415.3290.563.83690,213-8.12-84.18%

Clearside Biomedical Description

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision.
Your Recent History
NASDAQ
CLSD
Clearside ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220629 18:45:21